Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery - 28/12/18
Highlights |
• | Treating MDR-TB is complicated, long and expensive. |
• | Bedaquiline (BQ) is a new active drug to treat MDR-TB. |
• | No study evaluated safety and effectiveness of surgery in BQ-treated patients. |
• | 57 BQ-exposed cases resistant to 7 drugs (median) underwent surgery in 9 countries. |
• | 60% of cases initiated BQ after surgery, 36.4% before and completed it afterwards. |
• | 90% culture-converted and 69.1% achieved treatment success at the end of treatment. |
Summary |
Objectives |
No study evaluated the contribution of adjunctive surgery in bedaquiline-treated patients. This study describes treatment outcomes and complications in a cohort of drug-resistant pulmonary tuberculosis (TB) cases treated with bedaquiline-containing regimens undergoing surgery.
Methods |
This retrospective observational study recruited patients treated for TB in 12 centres in 9 countries between January 2007 and March 2015.
Patients who had surgical indications in a bedaquiline-treated programme-based cohort were selected and surgery-related information was collected. Patient characteristics and surgical indications were described together with type of operation, surgical complications, bacteriological conversion rates, and treatment outcomes. Treatment outcomes were evaluated according to the time of surgery.
Results |
57 bedaquiline-exposed cases resistant to a median of 7 drugs had indication for surgery (52 retreatments; 50 extensively drug-resistant (XDR) or pre XDR-TB). Sixty percent of cases initiated bedaquiline treatment following surgery, while 36.4% underwent the bedaquiline regimen before surgery and completed it after the operation. At treatment completion 90% culture-converted with 69.1% achieving treatment success; 21.8% had unfavourable outcomes (20.0% treatment failure, 1.8% lost to follow-up), and 9.1% were still undergoing treatment.
Conclusions |
The study results suggest that bedaquiline and surgery can be safely and effectively combined in selected cases with a specific indication.
Le texte complet de cet article est disponible en PDF.Keywords : TB, MDR-TB, XDR-TB, surgery, pulmonary rehabilitation
Plan
Vol 78 - N° 1
P. 35-39 - janvier 2019 Retour au numéro
Article précédent
- Mycobacterium tuberculosis prosthetic joint infections: A case series and literature review
- Fabrice Uhel, Gregory Corvaisier, Yves Poinsignon, Catherine Chirouze, Guillaume Beraud, Olivier Grossi, Nicolas Varache, Cédric Arvieux, Rozenn Le Berre, Pierre Tattevin, for the Groupe d'Epidémiologie et Recherche en Infectiologie Clinique Centre-Ouest (GERICCO)
- Clinical outcome and risk factors for failure in late acute prosthetic joint infections treated with debridement and implant retention
- Marjan Wouthuyzen-Bakker, Marine Sebillotte, Jose Lomas, Adrian Taylor, Eva Benavent Palomares, Oscar Murillo, Javad Parvizi, Noam Shohat, Javier Cobo Reinoso, Rosa Escudero Sánchez, Marta Fernandez-Sampedro, Eric Senneville, Kaisa Huotari, José Maria Barbero, Joaquín Garcia-Cañete, Jaime Lora-Tamayo, Matteo Carlo Ferrari, Danguole Vaznaisiene, Erlangga Yusuf, Craig Aboltins, Rihard Trebse, Mauro José Salles, Natividad Benito, Andrea Vila, Maria Dolores Del Toro, Tobias Siegfried Kramer, Sabine Petersdorf, Vicens Diaz-Brito, Zeliha Kocak Tufan, Marisa Sanchez, Cédric Arvieux, Alex Soriano, ESCMID Study Group for Implant-Associated Infections (ESGIAI)
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?